Novel color vision assessment tool: AIM color detection and discrimination - Journal of Translational Medicine Background Color vision assessment is essential in clinical practice, yet different tests exhibit distinct strengths and limitations. Here we apply a psychophysical paradigm, Angular Indication Measur...

Key findings highlight AIM's comparable accuracy to anomaloscopes, with high repeatability and potential for clinical and research applications.

Read the full paper here: link.springer.com/article/10.1...

Through adaptive, self-administered charts, AIM enables precise detection and discrimination of color deficiencies, validated in color-normal individuals and those with CVD using machine learning for classification.

This study introduces Angular Indication Measurement (AIM) Color, a novel psychophysical paradigm designed to overcome limitations in traditional color vision tests, such as extended testing times and reduced sensitivity.

Just in time for the holidays —exciting news!
Our latest validation study is out in the Journal of Translational Medicine:
"Novel color vision assessment tool: AIM color detection and discrimination" by Jingyi He, @janskerswetat.bsky.social , & Peter Bex.

We received the news that a paper on visual motion & form coherence processing in cerebral visual impairment using our FInD technology, published in Developmental Medicine & Child Neurology, is among the top 10 most-cited papers of 2023 by Mac Keith Press! #visionresearch #CVI

Motion and form coherence processing in individuals with cerebral visual impairment In participants with cerebral visual impairment (CVI), motion (but not form) coherence thresholds were significantly higher compared to controls. These psychophysical results support the notion o...

Here is the link:
doi.org/10.1111/dmcn...

We received the news that a paper on visual motion & form coherence processing in cerebral visual impairment using our FInD technology, published in Developmental Medicine & Child Neurology, is among the top 10 most-cited papers of 2023 by Mac Keith Press! #visionresearch #CVI

Looking forward to it!

Join us at the ARVO Annual Meeting, the premier gathering for eye & vision scientists globally, held May 4-8, 2025, in Salt Lake City, Utah. We will present 3 different projects, stay tuned for more information in the coming days. #ARVO2025 #VisionScience @arvoinfo.bsky.social perzeption.vision/Blog

Important Team Update: Orion Wilmerding, software architect and previous founder in the medical device sector, has joined the PerZeption team as Chief Technology Officer. #visionscience #medicaldevice
www.prnewswire.com/news-release...

Our PerZeption app’s tablet-based CVD screening got a spotlight in JOSAA! AIM & FInD methods showed strong results for efficient, accurate testing. Read more about how we’re advancing vision diagnostics in our latest blog perzeption.vision/Blog #VisionScience #ColorVision

One in four people—2.2 billion—face vision loss. Our mission is to prevent this with cutting-edge vision assessment software for clinicians. We’ve validated our app, scaled our tech, expanded our team, and redesigned our webpage. Our new app is ready—more updates soon. perzeption.vision/Blog